Dr. Raj Singh, MD

Raj Singh, M.D., is a board-certified radiation oncologist at the Eugene M. and Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital. He specializes in treating patients with central nervous system cancers, including primary and metastatic cancers involving the brain or spine, head and neck cancers, skin cancers and thoracic malignancies such as lung cancer. Prior to joining Baptist Health, Dr. Singh was an Assistant Professor of Radiation Oncology at The Ohio State University Wexner Medical Center and a radiation oncologist at The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, where he received both the Association of Residents in Radiation Oncology Educator of the Year and the James Physician Patient Champion Awards. After graduating cum laude from Duke University with a Bachelor of Science in Economics with distinction, Dr. Singh earned his medical degree at Marshall University Joan C. Edwards School of Medicine in …Huntington, West Virginia, where he was inducted into the Alpha Omega Alpha Honor Medical Society, received the Arnold P. Gold Humanism in Medicine Award and selected by his classmates to receive the Peer Choice Award of his graduating class. He completed his transitional year internship at Mather Hospital, part of Northwell Health, in Port Jefferson, New York and his radiation oncology residency at Virginia Commonwealth University, Massey Comprehensive Cancer Center in Richmond, Virginia, where he served as chief resident during his final year and received the Radiological Society of North America Roentgen Research Award. Much of Dr. Singh’s research has focused on stereotactic radiosurgery (SRS) for brain metastases and stereotactic ablative radiation therapy (SABR) for metastatic disease outside of the brain. He has a particular interest in determining the specific patient populations that may benefit the most from aggressive local therapy based on the original cancer type and other patient and tumor characteristics. Dr. Singh has published on the utility of SABR in early-stage small-cell lung cancer and on SRS for non-malignant conditions, such as dural arteriovenous fistulas, vestibular schwannomas, cavernous malformations and trigeminal neuralgia, among others. In addition, he has assessed the potential benefit of more aggressive radiation therapy approaches for glioblastoma and meningiomas and optimal treatment approaches for oropharyngeal cancers. Dr. Singh has presented at multiple national and international conferences and has more than 75 peer-reviewed publications in numerous medical journals, including JAMA Oncology, Cancer, International Journal of Radiation Oncology - Biology - Physics, Radiotherapy & Oncology, Oral Oncology, Neurosurgery, Journal of Neurosurgery, Journal of Neuro-Oncology, and Neuro-Oncology Advances. In addition to his clinical and research work, he has been involved in the education and mentorship of resident physicians, fellows and medical students. He also contributes to the scientific community as a member of several professional organizations and reviewer for numerous high-impact medical journals. Dr. Singh prioritizes patient education and aims to ensure that his patients understand their diagnosis, treatment options and follow-up plans so they feel confident in their care and empowered to make decisions based on their personal value system. He also strives to address his patients’ concerns and any potential obstacles to accessing medical treatment. During his free time, Dr. Singh enjoys spending time at the beach, hiking and playing tennis and video games.